Neutrophils are the immune system’s most abundant white blood cells and typically the first to arrive at a site of infection or injury, where they kill invading microbes through a combination of engulfment, toxic chemical release, and the casting of DNA-based traps. But their role extends well beyond simple germ-killing. Neutrophils shape the broader inflammatory response, communicate with other immune cells, and even influence whether inflammation resolves cleanly or spirals into tissue damage. That dual nature, protective yet potentially destructive, makes them central players in everything from wound healing to autoimmune disease.
Getting to the Scene
Before neutrophils can fight anything, they have to leave the bloodstream and reach the tissue where trouble is brewing. This exit, called extravasation, is a tightly choreographed sequence of interactions between neutrophils and the cells lining blood vessel walls. Neutrophils first slow down by loosely tethering to the vessel lining, then roll along it, then grip firmly and squeeze between endothelial cells to enter the surrounding tissue.1PubMed Central. Mechanisms of neutrophil transendothelial migration Chemical signals released by damaged or infected cells guide them toward the right spot, much like a trail of breadcrumbs.
Under normal conditions, this process is fast. Neutrophils circulate in huge numbers, and the bone marrow can ramp up production dramatically when demand spikes. During severe infection, the body activates what researchers call emergency granulopoiesis, a shift in bone marrow output that floods the bloodstream with fresh neutrophils far beyond the usual rate.2PubMed Central. G-CSF-Induced Emergency Granulopoiesis Modulates Neutrophil Effector Function in Mice This surge is driven largely by a signaling protein called G-CSF, which doctors also use as a drug to boost neutrophil counts in patients undergoing chemotherapy.
How Neutrophils Kill
Once neutrophils reach the infection, they have several weapons at their disposal. The most direct is phagocytosis: the neutrophil wraps itself around a bacterium or fungal cell and pulls it inside a sealed compartment. What happens next is often called the respiratory burst, a misleading name since it has nothing to do with breathing. The neutrophil assembles a multi-part enzyme complex called NADPH oxidase on the wall of that internal compartment. This enzyme churns out superoxide, which then gets converted into a cascade of other reactive oxygen species, including hydrogen peroxide and hypochlorous acid, essentially a diluted form of bleach.3PubMed. Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane These chemicals are extremely toxic to microbes trapped inside the compartment.
The assembly of NADPH oxidase requires signals from receptors on the neutrophil’s surface that recognize microbial patterns or antibody-coated targets. When those receptors engage, they trigger a chain of intracellular events that bring the enzyme’s scattered components together into a functional unit.4PubMed Central. Neutrophils to the ROScue: Mechanisms of NADPH Oxidase Activation and Bacterial Resistance People born with genetic defects in any of these components develop chronic granulomatous disease, a condition in which neutrophils can still swallow bacteria but cannot kill them effectively, leading to severe, recurrent infections. This genetic disease illustrates just how essential the oxidative burst is.
Granules and Their Sequential Deployment
Neutrophils carry four distinct types of internal storage compartments, or granules, each packed with different antimicrobial proteins and enzymes. These are not released all at once. Instead, they deploy in a specific sequence as the neutrophil moves from the bloodstream into infected tissue. Secretory vesicles open first, helping the neutrophil adhere to and cross the vessel wall. Specific granules and gelatinase granules come next, releasing enzymes that help the cell migrate through tissue and begin creating a hostile environment for pathogens. Last to open are the azurophilic granules, which deliver the most potent antimicrobial proteins directly to the site of infection and into the compartments where engulfed microbes are being digested.5PubMed. Armed for destruction: formation, function and trafficking of neutrophil granules
This ordered release is a form of damage control. The most destructive granule contents stay locked away until the neutrophil is right where it needs to be. If everything dumped out in the bloodstream, the collateral damage to healthy tissue would be enormous. When granule release does go wrong, either too early or in excessive amounts, it contributes to the tissue destruction seen in conditions like severe arthritis or acute lung injury.
Neutrophil Extracellular Traps
One of the more dramatic neutrophil weapons was discovered only in the early 2000s. Neutrophils can eject their own DNA, along with antimicrobial proteins from their granules, to form web-like structures called neutrophil extracellular traps, or NETs. These sticky nets physically snare bacteria and fungi, preventing them from spreading while exposing them to concentrated antimicrobial chemicals. The process that forms NETs often kills the neutrophil itself, though some evidence suggests neutrophils can sometimes release NETs and survive.
NETs are especially useful against targets too large for a single neutrophil to engulf. In the case of the fungus Candida, neutrophils form coordinated swarms around clusters of fungal cells. Research using specialized microfluidic assays showed that swarming neutrophils use both their oxidative burst enzymes and NET release within the swarm to delay fungal germination and restrict growth.6PubMed Central. Neutrophil swarming delays the growth of clusters of pathogenic fungi This cooperative swarming behavior suggests neutrophils are not just lone warriors but can mount organized, collective attacks.
The trouble is that NETs, being made of DNA and loaded with inflammatory proteins, are also excellent at provoking the immune system’s own cells. In systemic lupus erythematosus (SLE), an imbalance between NET formation and NET clearance plays a prominent role in driving autoimmunity. When the body fails to clean up NETs efficiently, the exposed DNA and associated proteins become targets for auto-antibodies, feeding a cycle of inflammation that damages the kidneys, skin, and other organs.7PubMed Central. Neutrophil Extracellular Traps and Systemic Lupus Erythematosus
How Inflammation Resolves
Neutrophils are short-lived cells that die by programmed cell death, or apoptosis, within hours to a couple of days of arriving at an inflammatory site. This built-in expiration date is not a bug; it is a feature. Dying neutrophils are swallowed by macrophages in a clean-up process called efferocytosis. When macrophages engulf these apoptotic neutrophils, they receive chemical signals that shift their behavior from pro-inflammatory to anti-inflammatory, actively promoting tissue repair.8PubMed Central. Clearance of apoptotic neutrophils and resolution of inflammation In the gut, this macrophage reprogramming after efferocytosis is essential for repairing the intestinal lining after inflammation.9PubMed Central. Macrophage COX2 Mediates Efferocytosis, Resolution Reprogramming, and Intestinal Epithelial Repair
If neutrophils are not cleared promptly, they undergo secondary necrosis, basically bursting open and spilling their toxic contents into the tissue. That makes everything worse. The body also produces specialized lipid mediators called resolvins that act as stop signals. Resolvins limit further neutrophil migration into the tissue, promote scavenging of inflammatory chemicals, and enhance the phagocytic clean-up of debris.10Biochemical Journal. Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution A failure in any part of this resolution machinery can tip ordinary inflammation into chronic disease.
Reverse Migration and the Spread of Inflammation
For decades, scientists assumed neutrophil trafficking was a one-way trip: leave the blood, enter the tissue, do the job, die there. Advanced imaging in zebrafish and mice revealed something unexpected. Some neutrophils leave the inflamed site and crawl back through the vessel wall into the bloodstream, a phenomenon called reverse migration.11PubMed Central. Neutrophil reverse migration On one hand, this can help resolve local inflammation by reducing the number of neutrophils at the wound. On the other hand, these returning neutrophils are already activated, primed, and carrying inflammatory signals. When they re-enter the circulation, they can travel to distant organs and seed inflammation there, contributing to multi-organ damage.12PubMed. MCTR1 ameliorates LPS-induced lung injury by inhibiting neutrophil reverse transendothelial migration
A key molecular gatekeeper in this process is a junctional adhesion molecule called JAM-C, which normally sits at the seams between endothelial cells and enforces directionality, ensuring neutrophils move outward into tissue rather than backward. When JAM-C expression drops, as it does during ischemia-reperfusion injury, reverse migration increases and can spread inflammation to remote sites.13PubMed Central. The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo This finding has practical implications for organ transplantation and heart attacks, where reperfusion after a period of blood-flow interruption is a known trigger for widespread inflammatory damage.
Collateral Damage in Sepsis and Organ Injury
Sepsis is the clearest example of neutrophil-mediated collateral damage. In sepsis-induced acute lung injury, the interplay between neutrophils and the endothelial cells lining lung blood vessels becomes destructive. Neutrophils that pile into the lungs release reactive oxygen species, granule enzymes, and NETs, all of which damage the delicate alveolar walls and increase vascular permeability, letting fluid flood the air spaces.14PubMed Central. Unraveling the deadly dance: endothelial cells and neutrophils in sepsis-induced acute lung injury/acute respiratory distress syndrome The result is acute respiratory distress syndrome (ARDS), one of the leading causes of death in intensive care units.
Similar neutrophil-driven damage occurs during ischemia-reperfusion injury, which happens when blood flow returns to tissue after a period of oxygen deprivation, as during a heart attack, stroke, or organ transplant. In the heart, neutrophils are the earliest inflammatory cells to arrive after reperfusion, peaking around 24 hours later. During this window, pro-inflammatory neutrophils release reactive oxygen species, inflammatory cytokines, and NETs that promote heart muscle cell death and amplify tissue damage.15Burns & Trauma. Neutrophils and neutrophil extracellular traps in ischaemia–reperfusion injury: pathophysiological roles and therapeutic potential In transplanted kidneys, dying tubular cells release damage signals that drive NETosis, amplifying renal inflammation and worsening graft outcomes.16PubMed Central. Updated Views on Neutrophil Responses in Ischemia-Reperfusion Injury
Neutrophils Are Not All Alike
The old textbook image of neutrophils as a uniform population of interchangeable killing machines has given way to a more nuanced picture. One well-studied example of neutrophil diversity involves low-density neutrophils (LDNs), a subpopulation that separates out differently from normal neutrophils in standard blood processing. LDNs are considered highly pro-inflammatory because they spontaneously form NETs at elevated rates, produce more inflammatory cytokines, and are toxic to endothelial cells. Their numbers rise in many inflammatory and autoimmune conditions, and higher LDN counts correlate with greater disease severity.17PubMed Central. Low-Density Granulocytes in Immune-Mediated Inflammatory Diseases LDNs also play roles in infections and cancer, where they can regulate both innate and adaptive immune responses.18PubMed Central. Interaction of low-density neutrophils with other immune cells in the mechanism of inflammation
In the context of tumors, neutrophil diversity takes on a different dimension. Tumor-associated neutrophils can polarize into anti-tumor “N1” or pro-tumor “N2” states, loosely analogous to the M1/M2 spectrum described for macrophages. N1 neutrophils are cytotoxic to cancer cells, while N2 neutrophils promote tumor growth and suppress immune surveillance. Signaling molecules in the tumor microenvironment, particularly TGF-beta, push neutrophils toward the N2 phenotype.19PubMed Central. Polarization of Tumor-Associated Neutrophil (TAN) Phenotype by TGF-β: “N1” versus “N2” TAN This has led researchers to explore whether blocking TGF-beta signaling could flip tumor neutrophils back to the cancer-fighting N1 state.
Bridging Innate and Adaptive Immunity
Neutrophils have traditionally been classified as purely innate immune cells, unable to participate in the targeted, memory-based responses carried out by T and B cells. That boundary has blurred. Human neutrophils can function as antigen-presenting cells, displaying fragments of viral and bacterial proteins on their surface in a way that activates memory T cells. In laboratory experiments, neutrophils pulsed with antigens from cytomegalovirus or influenza were able to present those antigens to T cells in a manner dependent on the same molecular machinery that professional antigen-presenting cells use.20PubMed Central. Neutrophils acquire the capacity for antigen presentation to memory CD4+ T cells in vitro and ex vivo Given that neutrophils vastly outnumber conventional antigen-presenting cells in blood, even modest antigen-presenting activity per cell could add up to a significant influence on T-cell responses.
Mouse studies have pushed this further, showing that neutrophils can prime naive T cells to develop into specific inflammatory subtypes without needing any added cytokines from other cells.21International Immunology. Mouse neutrophils are professional antigen-presenting cells programmed to instruct Th1 and Th17 T-cell differentiation If this holds true in humans under real infection conditions, it would mean neutrophils are not just the infantry of the immune system but also serve as intelligence officers, shaping the strategic direction of the adaptive immune response.
Neutrophil Metabolism Fuels Their Firepower
Neutrophils rely overwhelmingly on glucose metabolism rather than the mitochondrial pathways that power most other cells. This makes them fast and fuel-efficient in the low-oxygen environments found inside abscesses and inflamed tissues, where oxygen-dependent energy production would stall. Recent work has shown that neutrophils actively rewire their sugar-burning pathways to sustain different functions: glycolysis powers phagocytosis and the oxidative burst, while mitochondrial activity, though limited, helps regulate whether a neutrophil releases granule contents or forms NETs.22PubMed Central. Live fast, die young: neutrophils streamline their metabolism to maximize inflammation In other words, how a neutrophil routes its fuel determines which weapon it deploys. Researchers are interested in whether metabolic manipulation could steer neutrophil behavior therapeutically, dampening harmful NET formation without crippling the cell’s ability to eat and kill bacteria.
The Microbiome Connection
The relationship between neutrophils and the trillions of microbes living in and on the body is reciprocal. Microbial products and metabolites derived from the gut microbiome influence neutrophil production in the bone marrow and fine-tune their functional readiness in the blood.23PubMed Central. Cross talk between neutrophils and the microbiota In return, neutrophils patrol the gut lining and help contain the microbiome, preventing commensal bacteria from crossing into sterile tissue. Disruption of this cross-talk, whether by antibiotic use, immune deficiency, or chronic disease, can destabilize both the microbial community and the neutrophil response, creating a feedback loop that promotes chronic inflammation.
Aging Neutrophils Lose Their Edge
As people age, neutrophil function declines in several ways. Older neutrophils migrate less accurately toward infection sites, so instead of heading straight for a wound, they wander, arriving late and sometimes ending up in the wrong tissue entirely. Their ability to engulf bacteria weakens due to changes in the surface receptors they use to recognize targets. On top of that, aged neutrophils show abnormal signaling through their pattern-recognition receptors and are more prone to premature death.24PubMed Central. Unraveling immunosenescence in sepsis: from cellular mechanisms to therapeutics – Section: Neutrophils in aged individuals with sepsis These deficits help explain why older adults are more vulnerable to infections like pneumonia and why sepsis carries a higher mortality in elderly patients. The total number of circulating neutrophils may stay roughly the same with age, but the cells themselves become less competent at their jobs.
The Circadian Clock Inside Every Neutrophil
Immune responses are not equally strong around the clock. Research has identified a light-regulated internal timer within neutrophils that controls their bactericidal activity over the course of the day. Bacterial clearance tends to be strongest during an organism’s active phase, synchronized with waking hours in humans. This cell-intrinsic clock means a neutrophil’s killing power at noon and midnight is genuinely different, not because of cortisol or other hormonal fluctuations alone, but because the neutrophil itself keeps time.25PubMed. A light-regulated circadian timer optimizes neutrophil bactericidal activity to boost daytime immunity This has implications for everything from infection susceptibility (late-night shifts may not just be tiring; they may coincide with weaker innate immunity) to the timing of vaccinations and surgeries.
Therapeutic Targeting of Neutrophils
Because neutrophils sit at the intersection of defense and damage, modulating their activity is an active area of drug development. The challenge is delicate: you want to dial down neutrophil-driven tissue destruction without leaving the patient defenseless against infection. One promising avenue involves nanoparticle-based delivery systems designed to deliver anti-inflammatory drugs directly to neutrophils or to the sites where NETs are causing problems. These systems can regulate excessive neutrophil activity through targeted drug delivery, alteration of gene expression, or inhibition of neutrophil recruitment. Separately, nanotechnology-based approaches can break down NETs after they have formed or prevent their formation in the first place.26PubMed Central. Advanced Nanoparticle Therapeutics for Targeting Neutrophils in Inflammatory Diseases
Other strategies in development focus on blocking the molecular signals that enable reverse migration, preventing activated neutrophils from spreading inflammation to distant organs. The resolvin pathways mentioned earlier are another therapeutic target: synthetic versions of these natural stop signals could help shut down runaway neutrophil-driven inflammation in conditions like ARDS or rheumatoid arthritis. None of these approaches has fully matured into standard clinical practice yet, but the breadth of the pipeline reflects how central neutrophil biology has become to understanding inflammatory disease.
Neutrophils Across the Animal Kingdom
Neutrophils are not unique to mammals. Cells with similar functions, including phagocytosis, oxidative burst, degranulation, and directed motility, exist across a wide range of animal species. What differs is how prominent they are. The proportion of neutrophils (or their equivalents, called heterophils in birds and reptiles) in blood varies substantially between species, suggesting that evolutionary pressures in different environments have shaped how much each lineage relies on this particular immune cell.27eLife. In-silico analysis of myeloid cells across the animal kingdom reveals neutrophil evolution by colony-stimulating factors Colony-stimulating factors, the same family of proteins used clinically to boost neutrophil counts in chemotherapy patients, appear to have been key drivers of this evolutionary diversification. Understanding how neutrophils evolved helps researchers identify which of their functions are truly ancient and conserved, and which are more recently acquired refinements specific to mammalian immunity.